Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Illingworth

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Lab Animal|December 20, 2019
Embracing changeFatima Trujillo, Laura Illingworth
Heart (British Cardiac Society)|December 7, 2019
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic riskFrederik Hendrik Verbrugge, Anne-Céline Martin, Deborah Siegal, et al.
Clinical Cardiology|March 16, 2019
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registryCarlos Jerjes-Sanchez, Ramon Corbalan, Antonio C P Barretto, et al.
Shock (Augusta, Ga.)|September 7, 2019
EP2 Receptor Blockade Attenuates COX-2 Upregulation During Intestinal InflammationJamie Golden, Laura Illingworth, Patil Kavarian, et al.
Journal of Pediatric Surgery|April 12, 2018
Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitisMubina Isani, Laura Illingworth, Eliot Herman, et al.
Plos One|June 23, 2018
Lactobacillus murinus HF12 colonizes neonatal gut and protects rats from necrotizing enterocolitisMubina Isani, Brandon A Bell, Patrick T Delaplain, et al.
The American Journal of Medicine|July 16, 2019
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AFFreek W A Verheugt, Giuseppe Ambrosio, Dan Atar, et al.
JAMA Cardiology|May 9, 2019
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF RegistryRamon Corbalan, Jean-Pierre Bassand, Laura Illingworth, et al.
Journal of the American Heart Association|February 6, 2019
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF RegistryShinya Goto, Pantep Angchaisuksiri, Jean-Pierre Bassand, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Lab Animal|December 20, 2019
Embracing changeFatima Trujillo, Laura Illingworth
Heart (British Cardiac Society)|December 7, 2019
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic riskFrederik Hendrik Verbrugge, Anne-Céline Martin, Deborah Siegal, et al.
Clinical Cardiology|March 16, 2019
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registryCarlos Jerjes-Sanchez, Ramon Corbalan, Antonio C P Barretto, et al.
Shock (Augusta, Ga.)|September 7, 2019
EP2 Receptor Blockade Attenuates COX-2 Upregulation During Intestinal InflammationJamie Golden, Laura Illingworth, Patil Kavarian, et al.
Journal of Pediatric Surgery|April 12, 2018
Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitisMubina Isani, Laura Illingworth, Eliot Herman, et al.
Plos One|June 23, 2018
Lactobacillus murinus HF12 colonizes neonatal gut and protects rats from necrotizing enterocolitisMubina Isani, Brandon A Bell, Patrick T Delaplain, et al.
The American Journal of Medicine|July 16, 2019
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AFFreek W A Verheugt, Giuseppe Ambrosio, Dan Atar, et al.
JAMA Cardiology|May 9, 2019
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF RegistryRamon Corbalan, Jean-Pierre Bassand, Laura Illingworth, et al.
Journal of the American Heart Association|February 6, 2019
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF RegistryShinya Goto, Pantep Angchaisuksiri, Jean-Pierre Bassand, et al.
Pageof 1